- Home
- TRGP vs GEHC Comparison
TRGP vs GEHC Comparison
Compare TRGP & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRGP | GEHC |
|---|---|---|
| Founded | 2005 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Computer Software: Prepackaged Software |
| Sector | Utilities | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.8B | 33.1B |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | TRGP | GEHC |
|---|---|---|
| Price | $178.49 | $83.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 9 |
| Target Price | ★ $212.00 | $86.67 |
| AVG Volume (30 Days) | 1.7M | ★ 3.9M |
| Earning Date | 11-05-2025 | 10-29-2025 |
| Dividend Yield | ★ 2.24% | 0.17% |
| EPS Growth | ★ 34.09 | 32.35 |
| EPS | ★ 7.42 | 4.83 |
| Revenue | $17,378,100,000.00 | ★ $20,246,000,000.00 |
| Revenue This Year | $12.72 | $6.33 |
| Revenue Next Year | $31.42 | $4.38 |
| P/E Ratio | $24.13 | ★ $17.16 |
| Revenue Growth | ★ 7.17 | 3.51 |
| 52 Week Low | $144.14 | $57.65 |
| 52 Week High | $218.51 | $94.80 |
Technical Indicators
Market Signals| Indicator | TRGP | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 53.67 | 57.89 |
| Support Level | $176.18 | $81.74 |
| Resistance Level | $182.44 | $86.19 |
| Average True Range (ATR) | 4.68 | 2.15 |
| MACD | -0.73 | -0.24 |
| Stochastic Oscillator | 42.11 | 56.43 |
Price Performance
Historical ComparisonAbout TRGP Targa Resources Inc.
Targa Resources is a midstream firm that primarily operates gathering and processing assets with substantial positions in the Permian, Stack, Scoop, and Bakken plays. It has fractionation capacity at Mont Belvieu and operates a liquefied petroleum gas export terminal. The Grand Prix natural gas liquids pipeline is another important asset.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).